Affordable Coding for Small Share Market Traders
Dabur India Ltd.’s Q2 FY26 results have been underwhelming, with Systematix maintaining a ‘Hold’ rating due to an unconvincing outlook. What does this mean for Indian investors?
Jubilant Pharmova Ltd. reported its Q2 FY26 results, with revenue and net earnings in line with estimates, while Ebitda beat expectations. Check the target price and analysis.
APL Apollo’s Q2 earnings beat estimates on superior margins, prompting Systematix to maintain a ‘Hold’ rating and raise the target price. What does this mean for Indian investors?
Raymond Lifestyle shares have been maintained as a ‘buy’ by Systematix post the company’s Q2 results. Check out the new target price and what it means for Indian investors.
Hindustan Unilever Ltd.’s Q2 review by Systematix indicates a ‘hold’ rating with a hiked target price, driven by improving demand trends and portfolio expansion into high-growth categories.